Five questions for Discuva's David Williams on antibiotic resistance
This article was originally published in Scrip
The problems posed by antibiotic resistance under the spotlight again. In 2014 so far we've seen the UK Prime Minister David Cameron declare action on the crisis of drug resistance to infections, the World Health Organization issue serve warnings for global collaboration and US push on with initiatives such as the GAIN (Generating Antibiotics Incentives Now) Act.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.